Who are New PEG based artificial tear's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Hyalein Mini Ophthalmic solution.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/new-peg-based-artificial-tear.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-14 · How we verify

New PEG based artificial tear — Competitive Intelligence Brief

New PEG based artificial tear (New PEG based artificial tear) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Artificial tear / Lubricating ophthalmic agent. Area: Ophthalmology.

marketed Artificial tear / Lubricating ophthalmic agent Ophthalmology Small molecule Live · refreshed every 30 min

Target snapshot

New PEG based artificial tear (New PEG based artificial tear) — Bp Consulting, Inc. PEG-based artificial tear provides lubrication and moisture to the ocular surface to relieve dry eye symptoms.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
New PEG based artificial tear TARGET	New PEG based artificial tear	Bp Consulting, Inc	marketed	Artificial tear / Lubricating ophthalmic agent
Hyalein Mini Ophthalmic solution	Hyalein Mini Ophthalmic solution	Otsuka Pharmaceutical Co., Ltd.	phase 3	Artificial tear / Lubricating ophthalmic agent	Ocular surface (non-receptor mediated)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Artificial tear / Lubricating ophthalmic agent class)

Bp Consulting, Inc · 1 drug in this class
Otsuka Pharmaceutical Co., Ltd. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). New PEG based artificial tear — Competitive Intelligence Brief. https://druglandscape.com/ci/new-peg-based-artificial-tear. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab